AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PRFoods

Interim / Quarterly Report Feb 28, 2023

2223_rns_2023-02-28_25d29abe-b022-4696-9f92-d0268fb87a97.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

Company AS PRFoods

Type Company Release

Category Half-yearly financial report

Disclosure time 28 Feb 2023 19:01:51 +0200

Attachments:

  • PRF_interim_6m2022_2023 FINAL 2.pdf (http://oam.fi.ee/en/download?id=7071)

  • PRF_vahearuanne_6k2022_2023 FINAL 1.pdf (http://oam.fi.ee/en/download?id=7072)

Currency

Title

Consolidated Unaudited Interim Report of AS PRFoods for the 2nd quarter and 6 months of

Consolidated Unaudited Interim Report of AS PRFoods for the 2nd quarter and 6 months of 2022/2023 financial year

MANAGEMENT COMMENTARY

2022/23 financial year that started in July 2022 and represents very different group structure. Due to high leverage and losses, we divested from loss-making Finnish operations in 2022 and sold for profit our Swedish operations.

New group structure has fish processing business in Scotland and Saaremaa, Estonia, and farming operations in Estonia.

The Q2 and H1 sales were 7.3 and 11.9 million euros respectively, naturally less due to offload of Finnish operations, both processing and fish farming (15.3 million in Q2 last year and 29.5 million eur in H1). Better focus on Value Added Product sales and fresh fish sales from our farms, marked very sharp turnaround in profit.

First time in post-covid environment all our operational subsidiaries (Saare Kala Tootmine, Redstorm, JRJ) showed positive EBITDA and were profitable in Q2.

On consolidated basis our results improved drastically in Q2, both on year on year basis and quarter over quarter: EBITDA was 800,000 eur vs -300,000 eur in Q2 2021, improvement of over 360%. On net profit level our results improved by 1,3 million eur: net loss for period was -0.1 meur vs -1,4 meur last year. Our financial expenses decreased by 50% due to leverage. It is important to note that nearly 90% of Group's debt liabilities carry fixed interest (bonds and loans).

Operating profit increased by 120% and was 0.2 meur vs -1,2 meur last year.

PRFoods Net Debt is still very high, but we managed to improve our liquidity ratio back to 1.0. Despite volatility in food markets and high inflation environment, we see continued demand for our products and ability to transfer input price increases to product prices.

On 6 months basis, our consolidated net profit was 733,000 eur vs -2,12 million loss last year. Net profit includes one-off profit from sale of Swedish subsidiary.

While being more concentrated in our size, we are more focused on performance, and we believe we can achieve sustainable EBITDA profitability in our processing business. Fish Farming is seasonal operation still and next harvest season will after end of current financial year.

It has been tough road negotiating COVID, high inflation, war and breakdown of international logistics, but we have managed. Necessary product changes and management changes were completed, and new team is very ambitious and focussed on profitability. Enormous thank you goes out to all our employees who have shown commitment and resilience!

KEY RATIOS

INCOME STATEMENT

+--------------------------+------------+---------+------------+---------+
mln EUR
unless indicated otherwise 2Q 2022/2023 2021/2022 2Q 2021/2022 2020/2021

+--------------------------+------------+---------+------------+---------+
Sales

7,3
42,1 15,3 58,7
+--------------------------+------------+---------+------------+---------+
Gross profit

1,6
3,1 2,2 5
+--------------------------+------------+---------+------------+---------+
EBITDA from operations
+--------------------------+------------+---------+------------+---------+

0,8
-1,7 0,8 -1,2
EBITDA
+--------------------------+------------+---------+------------+---------+

0,8
-2,1 -0,3 -1,3
EBIT
+--------------------------+------------+---------+------------+---------+

0,2
-4,2 -1 -3,9
EBT
+--------------------------+------------+---------+------------+---------+

-0,0
-8,2 -1,4 -5
Net profit (loss)
+--------------------------+------------+---------+------------+---------+

-0,1
-8,2 -1,4 -5,2
Gross margin
22,1%
7,4% 14,1% 8,50%
+--------------------------+------------+---------+------------+---------+
Operational EBITDA margin
+--------------------------+------------+---------+------------+---------+
11,3% -4,1% 5,2% -2,1%
EBITDA margin
+--------------------------+------------+---------+------------+---------+

11,3%
-5,1% -2,1% -2,1%
$-6,4$ $-6,6$ $-6$
$-8,9$ $ $ $-8,5$ $\circ$ $\vert$
$-9,1$ $-8,8$ $ $
$15,1$ 8 $ $ $16,1$ 8
2,9% -9,9%
$-0,5$ $-19,5$ $ $
$-1,8$ $-19,4$
$-18,9$ % $-17,1$ %

BALANCE SHEET

mln EUR
unless indicated otherwise 31.12.2022 30.06.2022 31.12.2021 30.06.2021
Net debt 17, 7 24,7 24, 2 20, 9
Equity 7,5 8,1 14,9 15, 8
Working capital 0, 0 $-3, 2$ $-2,6$ $-2, 9$
Assets 32, 2 38,9 56,0 55, 3
Liquidity ratio 1,0x 0, 7x 0,9x 0, 9x
Equity ratio $23,3$ 8 $20,7$ $ $ $26,7$ $ $ $28,6$ 8
Gearing ratio $70,2$ $ $ $75,4$ 8 $61,8$ 8 $56,9$ $ $
Debt to total assets 0,8x 0, 8x 0,7x 0,7x
Net debt to operating EBITDA 21, 4x $-14, 5x$ $-14, 3x$ $-16, 9x$
ROE $-1,7$ % $-68,5\%$ $-26,7\%$ $-28,7$ $ $
ROA $[-0, 4\%]$ $[-17, 3\%]$ $[-7, 9\%]$ $-9,1$ 8

Consolidated Statement of Financial Position

EUR '000 -------- 31.12.2022 31.12.2021 30.06.2022
ASSETS
Cash and cash equivalents 386 4981
Receivables and prepayments 5016 4 4 6 3 2 5 6 7
Inventories 2089 4 596 2 196
Biological assets 0 1 4 5 2 3 3003
Total current assets 7491 14 080 7 876
Deferred tax assets 0 38 93
Long-term financial investments 304 300 229
Tangible assets 6944 14 655 8 8 8 2
Intangible assets 17 443 23 715 21 837
Total non-current assets 24 691 38 708 31041
TOTAL ASSETS 32 182 52 788 38 917
EQUITY AND LIABILITIES
Interest-bearing liabilities 2 777 6275 7 0 9 4
Payables and prepayments 4 672 11 666 3 9 7 8
Government grants 0 207 $\mathbf{0}$
Total current liabilities 7 449 18 148 11 072
Interest-bearing liabilities 15 270 18 180 17 725
Payables and prepayments 0 0 1 204
Deferred tax liabilities 1 644 1 877 1 599
Government grants $327$ 662 265
Total non-current liabilities 17 241 20 719 19 792
TOTAL LIABILITIES 24 690 38 867
-----
30865
Share capital 7 737 7 737 7 737
Share premium 14 007 14 007 14 007
Treasury shares $-390$ $-390$ $-390$
Statutory capital reserve 51 51 51
Currency translation differences 394 831 839
Retained profit (loss) $-14605$ -8 883 -14 391
Equity attributable to parent 7 194 13353 7 853
Non-controlling interest 297 568 199
TOTAL EOUITY 7491 13921 8 0 5 2
TOTAL EQUITY AND LIABILITIES 32 182 52 788 38 917

Consolidated Statement of Profit or Loss And Other Comprehensive Income

EUR '000 2Q 2022/2023 2Q 2021/2022 6m 2022/2023 6m 2021/2022
Revenue 7,300 15,292 11,910 29,499
Cost of goods sold $-5,688$ $-13,139$ $-9,785$ $-26,572$
Gross profit 1,612 2,153 2,125 2,927
Operating expenses $-1,379$ $-2,395$ $-2,493$ $-4,704$
Selling and distribution
expenses
$-671$ $-1,668$ $-1, 314$ $-3, 249$
Administrative expenses $-708$ $-727$ $-1,179$ $-1,455$
Other income / expense $-21$ 11 $-68$ 62
Fair value adjustment on
biological assets
$\Omega$ $-752$ $-170$ 68
Operating profit (loss) 212 $-983$ $-606$ $-1,647$
Financial income /
expenses
$-245$ $-384$ 1,447 $-368$
Profit (Loss) before tax $-33$ $-1,367$ $841$ $-2,015$
Income tax $-102$ $-17$
$-108$
$-109$
Net profit (loss) for the
period
$-135$
$-1,384$
733 $-2,124$
Net profit (loss)
attributable to:
Owners of the Parent
Company
$-210$
$-1,242$
668 $-2,160$
Non-controlling interests 75 $-142$ 66 36
Total net profit (loss)
for the period
$-135$ $-1,384$ 733 $-2,124$
Other comprehensive income
(loss) that may
subsequently be classified
to profit or loss:
Foreign currency
translation differences
0 384 $-445$ 272
Total comprehensive income
(expense)
$-135$ $-1,000$ 288
$-1,852$
Total comprehensive income
(expense) attributable to:
Owners of the Parent
Company
$-210$ $-858$ 223 $-1,888$
Non-controlling interests 75 $-142$ 66 36
Total comprehensive income
(expense) for the period
$-135$
$-1,000$
288 $-1,852$
Profit (Loss) per share
(EUR)


-0.01

-0.03

0.02


-0.06
+--------------------------+------------+------------+------------+------------+

+--------------------------+------------+------------+------------+------------+
Diluted profit (loss) per
share (EUR)
+--------------------------+------------+------------+------------+------------+

0.00

-0.03

0.01


-0.05

Indrek Kasela

AS PRFoods

Member of the Management Board

Phone:+372 452 1470

[email protected]

www.prfoods.ee (http://www.prfoods.ee)

Talk to a Data Expert

Have a question? We'll get back to you promptly.